News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
495,661 Results
Type
Article (8817)
Company Profile (143)
Press Release (486967)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (169336)
Career Advice (313)
Deals (26128)
Drug Delivery (9)
Drug Development (54340)
Employer Resources (14)
FDA (10071)
Job Trends (8768)
News (242555)
Policy (18284)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (564)
Accelerated approval (26)
ADA (25)
Adcomms (1)
Allergies (99)
Alliances (33727)
ALS (114)
Alzheimer's disease (997)
Antibody-drug conjugate (ADC) (293)
Approvals (10755)
Artificial intelligence (346)
ASCO (163)
Autoimmune disease (230)
Automation (30)
Bankruptcy (273)
Belgium (2)
Best Places to Work (7142)
BIO (37)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (149)
BioSpace Insights (19)
Biotechnology (91)
Bispecific (1)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (527)
Cancer (3843)
Cardiovascular disease (229)
Career advice (251)
Career pathing (1)
CAR-T (180)
CDC (1)
CDMO (23)
Celiac Disease (1)
Cell therapy (501)
Cervical cancer (38)
Clinical research (49367)
Collaboration (1341)
Commercialization (4)
Compensation (1541)
Complete response letters (35)
COVID-19 (788)
CRISPR (67)
C-suite (854)
Cystic fibrosis (99)
Data (6125)
Denatured (5)
Depression (108)
Dermatology (72)
Diabetes (384)
Diagnostics (4307)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (168)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (169)
Earnings (74666)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (89705)
Executive appointments (754)
Eye disease (2)
FDA (12923)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (1011)
Gene editing (130)
Generative AI (11)
Gene therapy (379)
GLP-1 (303)
Government (991)
Grass and pollen (2)
Guidances (283)
Healthcare (9712)
Hematology (98)
HIV (56)
Huntington's disease (24)
IgA nephropathy (78)
Immunology and inflammation (114)
Immuno-oncology (61)
Indications (169)
Infectious disease (981)
Inflammatory bowel disease (131)
Inflation Reduction Act (5)
Influenza (86)
Intellectual property (266)
Interviews (44)
IPO (12550)
IRA (2)
Job creations (1992)
Job search strategy (240)
JPM (2)
Kidney cancer (17)
Kidney disease (47)
Labor market (1)
Layoffs (67)
Legal (5234)
Licensing (22)
Liver cancer (46)
Longevity (20)
Lung cancer (561)
Lymphoma (263)
Machine learning (29)
Management (3)
Manufacturing (599)
Marketing (8)
MASH (119)
Medical affairs (2)
Medical device (8918)
Medtech (9082)
Mergers & acquisitions (14670)
Metabolic disorders (768)
mRNA (66)
Multiple sclerosis (122)
NASH (4)
Neurodegenerative disease (237)
Neuropsychiatric disorders (40)
Neuroscience (1931)
NextGen: Class of 2026 (3248)
Non-profit (915)
Now hiring (4)
Obesity (245)
Opinion (13)
Ovarian cancer (166)
Pain (188)
Pancreatic cancer (209)
Parkinson's disease (216)
Partnered (12)
Patents (510)
Patient recruitment (564)
Patient selection (4)
Peanut (32)
People (42156)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15902)
Phase 2 (22134)
Phase 3 (14927)
Pipeline (8043)
Policy (19)
Postmarket research (1601)
Preclinical (6697)
Press Release (34)
Prostate cancer (197)
Psychedelics (9)
Radiopharmaceuticals (197)
Rare diseases (624)
Real estate (3086)
Recruiting (6)
Regenerative medicine (5)
Regulatory (15407)
Reports (23)
Research institute (614)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (49)
Schizophrenia (104)
Series A (177)
Series B (140)
Service/supplier (5)
Sickle cell disease (65)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2081)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Tariffs (1)
The Weekly (1)
Vaccines (326)
Venture capital (18)
Weight loss (76)
Wet AMD (1)
Women's health (91)
Date
Today (17)
Last 7 days (309)
Last 30 days (1512)
Last 365 days (19551)
2026 (14317)
2025 (19749)
2024 (23573)
2023 (27214)
2022 (35316)
2021 (37880)
2020 (34193)
2019 (23978)
2018 (18038)
2017 (19279)
2016 (18410)
2015 (24894)
2014 (22118)
2013 (18450)
2012 (20480)
2011 (20724)
2010 (20514)
Location
Africa (240)
Alabama (81)
Alaska (3)
Arizona (316)
Arkansas (11)
Asia (19126)
Australia (2281)
California (12635)
Canada (3317)
China (598)
Colorado (508)
Connecticut (430)
Delaware (228)
Europe (27733)
Florida (1881)
Georgia (395)
Hawaii (3)
Idaho (46)
Illinois (754)
India (79)
Indiana (334)
Iowa (16)
Japan (440)
Kansas (105)
Kentucky (35)
Louisiana (27)
Maine (26)
Maryland (1250)
Massachusetts (8242)
Michigan (318)
Minnesota (578)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (61)
New Jersey (2769)
New Mexico (12)
New York (2964)
North Carolina (1348)
North Dakota (4)
Northern California (6350)
Ohio (304)
Oklahoma (14)
Oregon (16)
Pennsylvania (2332)
Puerto Rico (25)
Rhode Island (30)
South America (421)
South Carolina (81)
South Dakota (1)
Southern California (5244)
Tennessee (125)
Texas (2035)
United States (40849)
Utah (380)
Vermont (1)
Virginia (161)
Washington D.C. (39)
Washington State (980)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
495,661 Results for "amber ophthalmics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Susan G. Komen® Names Amber Guild President & CEO
August 12, 2026
·
4 min read
Press Releases
PharmFormulator LLC Launches Intelligence Platform to Bring Unprecedented Transparency to Ophthalmic Inactive Ingredients
September 24, 2026
·
1 min read
Press Releases
Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London
September 10, 2026
·
4 min read
Press Releases
ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
September 3, 2026
·
9 min read
Press Releases
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
March 2, 2026
·
6 min read
Press Releases
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation
August 19, 2026
·
5 min read
Press Releases
Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio
June 16, 2026
·
2 min read
Press Releases
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
April 9, 2026
·
3 min read
Press Releases
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
July 26, 2026
·
10 min read
Drug Development
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects
Amber Ophthalmics, Inc. (Amber) , a privately held, clinical stage biopharmaceutical company, announced today that Dr. Mark S. Gorovoy from Gorovoy M.D. Eye Specialists has enrolled the first patient in the AMB-01-006 (NEXPEDE-1) study.
August 18, 2023
·
2 min read
1 of 49,567
Next
